Stocks
Agios Pharmaceuticals (AGIO) Operating Income US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -378.4 | -389.0 | -391.5 | -425.7 | -472.1 | -475.5 | |||
| Changes by years, y/y, % | +13% | +3% | +1% | +9% | +11% | +7.0% | |||
Agios Pharmaceuticals. Operating Income, bln rub
Agios Pharmaceuticals. Operating Income, changes, %
Agios Pharmaceuticals. Operating Income, sum by quarters, bln rub
Agios Pharmaceuticals (AGIO) Operating Income US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Operating Income, bln rub | -106.6 | -127.1 | -116.9 | -121.6 | -110.0 | -475.5 | ||
| Changes by years, y/y, % | +16% | +20% | +14% | -3% | +3% | |||
| Changes by quarters, q/q, % | -15% | +19% | -8% | +4% | -10% | |||
